South San Francisco, CA
Sutro Biopharma, Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro Biopharma serves the pharmaceutical industries throughout the United States.
sutrobio.comThese are collections Sutro Biopharma is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$75,000,000
Post Ipo Debt
$140,000,000
Post Ipo Equity
$144,900,000
Post Ipo Equity
$75,000,000
Series E
$85,400,000
IPO
Unknown
Series D
$26,000,000
Series C
$16,500,000
Series C
$36,500,000
Series B
$15,000,000
Series B
$21,000,000
Series Unknown
$305,000
Series A
$1,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Sutro Biopharma.